Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Puma Biotechnology Inc - Common Stock
(NQ:
PBYI
)
8.880
-0.030 (-0.34%)
Streaming Delayed Price
Updated: 12:27 PM EDT, Aug 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
141,561
Open
8.955
Bid (Size)
8.870 (100)
Ask (Size)
8.890 (300)
Prev. Close
8.910
Today's Range
8.550 - 8.955
52wk Range
3.710 - 9.400
Shares Outstanding
47,509,765
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Puma Biotechnology Q2 Earnings Call Highlights
↗
August 07, 2026
Puma Biotechnology (NASDAQ:PBYI) reported second-quarter 2026 total revenue of $56.5 million, including $53.6 million in net product revenue from NERLYNX and $2.9 million in royalty revenue. The...
Via
MarketBeat
Topics
Earnings
Puma Biotechnology (NASDAQ:PBYI) Beats Q2 Estimates, but Soft Q3 Guidance Tempers Reaction
↗
August 06, 2026
Via
Chartmill
Performance
YTD
+53.9%
+53.9%
1 Month
+11.0%
+11.0%
3 Month
+24.4%
+24.4%
6 Month
+29.1%
+29.1%
1 Year
+83.1%
+83.1%
More News
Read More
Puma Biotechnology Reports Second Quarter 2026 Financial Results
August 06, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
August 05, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results
July 23, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) Beats Q1 Estimates, Raises Full-Year Guidance
↗
May 07, 2026
Via
Chartmill
Puma Biotechnology (NASDAQ:PBYI) Beats Q4 Estimates, Guides for Profitable 2026
↗
February 26, 2026
Via
Chartmill
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma (PBYI) Q1 2026 Earnings Call Transcript
↗
May 08, 2026
Via
The Motley Fool
Topics
Earnings
Puma Biotechnology Q1 Earnings Call Highlights
↗
May 08, 2026
Via
MarketBeat
Topics
Earnings
Puma Biotechnology Reports First Quarter 2026 Financial Results
May 07, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results
April 23, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?
↗
March 23, 2026
Via
The Motley Fool
Puma Biotech (PBYI) Earnings Call Transcript
↗
February 26, 2026
Via
The Motley Fool
Topics
Earnings
Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference
February 23, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
February 04, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
January 07, 2026
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
December 22, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2025
From
Puma Biotechnology, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 10, 2025
Via
Benzinga
Frequently Asked Questions
Is Puma Biotechnology Inc - Common Stock publicly traded?
Yes, Puma Biotechnology Inc - Common Stock is publicly traded.
What exchange does Puma Biotechnology Inc - Common Stock trade on?
Puma Biotechnology Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Puma Biotechnology Inc - Common Stock?
The ticker symbol for Puma Biotechnology Inc - Common Stock is PBYI on the Nasdaq Stock Market
What is the current price of Puma Biotechnology Inc - Common Stock?
The current price of Puma Biotechnology Inc - Common Stock is 8.880
When was Puma Biotechnology Inc - Common Stock last traded?
The last trade of Puma Biotechnology Inc - Common Stock was at 08/10/26 12:27 PM ET
What is the market capitalization of Puma Biotechnology Inc - Common Stock?
The market capitalization of Puma Biotechnology Inc - Common Stock is 421.89M
How many shares of Puma Biotechnology Inc - Common Stock are outstanding?
Puma Biotechnology Inc - Common Stock has 422M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
